Literature Collection

Magnifying Glass
Collection Insights

11K+

References

9K+

Articles

1500+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
11248 Results
5941
Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report
Type: Journal Article
Authors: Miriam Harris, Samantha Johnson, Sarah Mackin, Richard Saitz, Alexander Y. Walley, Jessica L. Taylor
Year: 2020
Publication Place: Baltimore, Maryland
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
HIT & Telehealth See topic collection
,
Opioids & Substance Use See topic collection
5942
Low intensity CBT interventions by general practitioners
Type: Book Chapter
Authors: Lee David
Year: 2010
Publication Place: New York, NY, US
Topic(s):
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5943
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline
Type: Journal Article
Authors: Henry A. Nasrallah, Jonathan M. Meyer, Donald C. Goff, Joseph P. McEvoy, Sonia M. Davis, T. S. Stroup, Jeffrey A. Lieberman
Year: 2006
Topic(s):
General Literature See topic collection
5944
Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report
Type: Journal Article
Authors: Lila Flavin, Babak Tofighi, Noa Krawczyk, Daniel Schatz, Jennifer McNeely, Jenna Butner
Year: 2022
Topic(s):
Healthcare Disparities See topic collection
,
HIT & Telehealth See topic collection
,
Opioids & Substance Use See topic collection
5946
Low-barrier buprenorphine treatment for people experiencing homelessness
Type: Journal Article
Authors: Claire L. Gibson, Emma Lo
Year: 2023
Topic(s):
Healthcare Disparities See topic collection
5947
Low-Burden Universal Substance Use Screening in a Primary Care Clinic to Lower Implementation Barriers
Type: Journal Article
Authors: D. Konkle-Parker, D. Williams, N. McAfee, J. A. Schumacher, J. Parker
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
5948
Low-intensity workers: Lessons learned from supervising primary care mental health workers and dilemmas associated with such roles
Type: Journal Article
Authors: M. Shepherd, M. Rosairo
Year: 2008
Publication Place: URL
Topic(s):
Education & Workforce See topic collection
5949
Low-Threshold Buprenorphine via Community Partnerships and Telemedicine-Case Reports of Expanding Access to Addiction Treatment During COVID-19
Type: Journal Article
Authors: Ximena A. Levander, Haven Wheelock, Justine Pope, Abby Lee, Kerith Hartmann, Sarah Abuelkhair, Jessica L. Gregg, Bradley M. Buchheit
Year: 2022
Topic(s):
Healthcare Disparities See topic collection
,
Healthcare Policy See topic collection
,
HIT & Telehealth See topic collection
,
Opioids & Substance Use See topic collection
5950
Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project
Type: Journal Article
Authors: Rojas Rojas, V. Di Beo, J. Delorme, T. Barre, P. Mathurin, C. Protopopescu, F. Bailly, M. Coste, N. Authier, M. P. Carrieri, B. Rolland, F. Marcellin
Year: 2019
Publication Place: Netherlands
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
5951
Lowering the Barriers to Medication Treatment for People with Opioid Use Disorder
Type: Government Report
Authors: Shoshana Aronowitz, Czarina Navos Behrends, Margaret Lowenstein, Bruce R. Schackman, Janet Weiner
Year: 2022
Publication Place: Philadelphia, PA
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5952
Lowering the Threshold: Models of Accessible Methadone and Buprenorphine Treatment
Type: Report
Authors: Elizabeth Keeney, Roxanne Saucier
Year: 2010
Publication Place: New York
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5953
m-Health applications for responding to drug use and associated harms
Type: Government Report
Authors: Alessandro Pirona, Michael P. Schaub, Jenny Yi-Chen Lee
Year: 2018
Abstract:

The fast developmental pace and widespread use of mobile technology and the internet mean that smartphone-based m-health (mobile health) applications (apps) have huge potential to further expand the reach of and access to drug-related health services towards a common goal of ensuring a healthier Europe. However, m-health for drug users and for health professionals in the field of drugs is still in its infancy and poorly documented at European Union (EU) level. The aim of this scoping study was therefore to carry out a first exploration of available smartphone applications in the drugs field within a European and global context. It explored the range of m-health applications available to users and professionals seeking information, support and advice in a wide range of EU languages. The systematic search of drug-related smartphone applications identified a total of 67 applications across the three main app stores. The identified m-health applications apply various technologies ranging from simple text-based content display to more advanced interactive functions such as video transmission, geo-tagging functions and automated personalised feedback. Based on the main objectives, content and target end-users of the 67 identified apps, three main groups of drug-related m-health applications emerged: apps that aim to disseminate drug-related information and advice, apps that provide interventions and support for drug users and apps for capacity building among health professionals. Most m-health apps address risk behaviour associated with drugs in general or drug use in specific settings (e.g. nightlife settings). Some drug-specific apps are available for more commonly used drugs such as cannabis and cocaine. A number of challenges for users, app developers and policymakers were identified in this scoping study. The lack of scientific evaluations of drug-related m-health interventions is concerning considering the increasing interest in and availability of such apps. Additionally, the lack of quality control of the content of these apps available to EU citizens, with no age limits, remains to be addressed. Global differences in therapeutic approaches used in the identified apps were apparent, especially between the United States and Europe, and this raises questions about the cross-cultural relevance of m-health applications. At the same time, the impact of the new EU General Data Protection Regulation may be of particular relevance in a context of fast global development of drug-related m-health apps available to EU citizens.

Topic(s):
Grey Literature See topic collection
,
HIT & Telehealth See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5954
Machine Learning Enhances the Efficiency of Cognitive Screenings for Primary Care
Type: Journal Article
Authors: Boaz Levy, Courtney Hess, Jacqueline Hogan, Matthew Hogan, James M. Ellison, Sarah Greenspan, Allison Elber, Kathryn Falcon, Daniel F. Driscoll, Ardeshir Z. Hashmi
Year: 2019
Publication Place: United States
Abstract:

BACKGROUND: Incorporation of cognitive screening into the busy primary care will require the development of highly efficient screening tools. We report the convergence validity of a very brief, self-administered, computerized assessment protocol against one of the most extensively used, clinician-administered instruments-the Montreal Cognitive Assessment (MoCA). METHOD: Two hundred six participants (mean age = 67.44, standard deviation [SD] = 11.63) completed the MoCA and the computerized test. Three machine learning algorithms (ie, Support Vector Machine, Random Forest, and Gradient Boosting Trees) were trained to classify participants according to the clinical cutoff score of the MoCA (ie, /=26, n = 165), suggesting greater sensitivity to age-related changes in cognitive functioning. CONCLUSION: Future studies should examine ways to improve the sensitivity of the computerized test by expanding the cognitive domains it measures without compromising its efficiency.

Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
5955
Mail-Back Envelopes for Retrieval of Opioids After Pediatric Surgery
Type: Journal Article
Authors: A. C. Adler, A. N. Yamani, C. D. Sutton, D. M. Guffey, A. Chandrakantan
Year: 2020
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
5958
Maintenance agonist treatments for opiate-dependent pregnant women
Type: Journal Article
Authors: S. Minozzi, L. Amato, S. Jahanfar, C. Bellisario, M. Ferri, M. Davoli
Year: 2020
Publication Place: England
Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
,
Opioids & Substance Use See topic collection
5959
Maintenance medication for opiate addiction: The foundation of recovery
Type: Journal Article
Authors: G. Bart
Year: 2012
Publication Place: England
Abstract: Illicit use of opiates is the fastest growing substance use problem in the United States, and the main reason for seeking addiction treatment services for illicit drug use throughout the world. It is associated with significant morbidity and mortality related to human immunodeficiency virus, hepatitis C, and overdose. Treatment for opiate addiction requires long-term management. Behavioral interventions alone have extremely poor outcomes, with more than 80% of patients returning to drug use. Similarly poor results are seen with medication-assisted detoxification. This article provides a topical review of the three medications approved by the Food and Drug Administration for long-term treatment of opiate dependence: the opioid-agonist methadone, the partial opioid-agonist buprenorphine, and the opioid-antagonist naltrexone. Basic mechanisms of action and treatment outcomes are described for each medication. Results indicate that maintenance medication provides the best opportunity for patients to achieve recovery from opiate addiction. Extensive literature and systematic reviews show that maintenance treatment with either methadone or buprenorphine is associated with retention in treatment, reduction in illicit opiate use, decreased craving, and improved social function. Oral naltrexone is ineffective in treating opiate addiction, but recent studies using extended-release naltrexone injections have shown promise. Although no direct comparisons between extended-release naltrexone injections and either methadone or buprenorphine exist, indirect comparison of retention shows inferior outcome compared with methadone and buprenorphine. Further work is needed to directly compare each medication and determine individual factors that can assist in medication selection. Until such time, selection of medication should be based on informed choice following a discussion of outcomes, risks, and benefits of each medication.
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Policy See topic collection
5960
Major depression in primary care: making the diagnosis
Type: Journal Article
Authors: C. W. Ng, C. H. How, Y. P. Ng
Year: 2016
Publication Place: Singapore
Topic(s):
Medically Unexplained Symptoms See topic collection